AIDS Treatment News

HIVandHepatitis.com on Retroviruses conference, related information:

LEDGF Integrase Inhibitors and Capsid Assembly Inhibitors Offer New Approaches for Blocking HIV Replication 3-2-2010

ACTG 5202 Shows Abacavir/lamivudine and Tenofovir/emtricitabine Provide Similar HIV Suppression at Low Viral Loads 3-2-2010

ACTG 5202 Sub-study Finds Lipoatrophy Uncommon, Antiretroviral Drugs Have Varying Effects on Bone and Body Fat 3-2-2010

Early Antiretroviral Therapy Reduces HIV Transmission in Discordant Heterosexual Couples 3-2-2010

CDC National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Releases New Strategic Plan 3-2-2010

Once-daily Boosted Darunavir (Prezista) Works as Well as Twice-daily for Treatment-experienced Patients 2-26-2010

Quitting Smoking Lowers Risk of Cardiovascular Disease in People with HIV 2-26-2010

HIV Raises Lung Cancer Risk, but Smoking Is a Much Stronger Predictor 2-26-2010

Research Sheds New Light on HIV in the Gut 2-26-2010

FDA Announces Preliminary Data Suggesting Heart Risk with Saquinavir (Invirase) plus Ritonavir (Norvir) 2-26-2010

Investigational Drug TBR-652 Demonstrates Dual Activity against CCR5 and CCR2 Co-receptors 2-23-2010

Poor CD4 Cell Recovery on Antiretroviral Therapy Is Linked to Late Treatment, Leads to Adverse Outcomes 2-23-2010

Treatment Intensification with Maraviroc (Selzentry) Did Not Raise CD4 Cell Counts in Small Study 2-23-2010

The U.S. HIV Research Agenda and the Future of PEPFAR 2-19-2010

Gilead's "Quad" Pill Matches Atripla, New Booster Cobicistat (GS 9350) Looks Good with Atazanavir (Reyataz) 2-19-2010

Vicriviroc Fails to Beat Stiff Competition, Merck Will Not File for Treatment-experienced Approval 2-19-2010

Conference on Retroviruses and Opportunistic Infections (CROI) Starts Tuesday in San Francisco 2-16-2010

Inflammatory Markers and Cardiovascular Risk in Treated and Untreated People with HIV 2-16-2010

Read more in HIVandHepatis.com, March 4, 2010.